Search Results - "Malinoski, F"

Strategies for prevention of RSV nosocomial infection by Groothuis, J, Bauman, J, Malinoski, F, Eggleston, M

“…Objective: To review the literature on respiratory syncytial virus (RSV) as a cause of nosocomial infections (NI) on neonatal intensive care units (NICUs) and…”
Get full text

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine by BLACK, STEVEN B, SHINEFIELD, HENRY R, HANSEN, JOHN, ELVIN, LAURA, LAUFER, DAGNA, MALINOSKI, FRANK

“…OBJECTIVE.To evaluate the impact of the introduction and routine use of seven valent pneumococcal conjugate vaccine on the epidemiology of invasive…”
Get full text

Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants by Rennels, Margaret B, Edwards, Kathryn M, Keyserling, Harry L, Reisinger, Keith S, Hogerman, Deborah A, Madore, Dace V, Chang, Ih, Paradiso, Peter R, Malinoski, Frank J, Kimura, Alan

“…To determine the safety and immunogenicity of heptavalent pneumococcal saccharide vaccine (serotypes 4, 6B, 9V, 14, 18C, 19F, 23F) individually conjugated to…”
Get full text

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient? by Fletcher, M A, Laufer, D S, McIntosh, E D G, Cimino, C, Malinoski, F J

“…Risk factors for invasive pneumococcal disease (IPD) include young and old age, comorbidities (such as splenic dysfunction, immunodeficiencies, chronic renal…”
Get more information

Immunologic Interference from Sequential Administration of Live Attenuated Alphavirus Vaccines by McClain, David J., Pittman, Phillip R., Ramsburg, Helen H., Nelson, Gene O., Rossi, Cindy A., Mangiafico, Joseph A., Schmaljohn, Alan L., Malinoski, Frank J.

“…Two different human vaccine trials examined interference arising from sequential administration of vaccines against heterologous alphaviruses. The first trial…”
Get full text

LB011-SUN PARENTERAL NUTRITION PRESCRIBING PATTERNS IN GERMANY: A MEDICAL CHART REVIEW OF 191 PRETERM INFANTS by Liu, F.X, Prinz, G.M, Macahilig, C, Malinoski, F, Turpin, R.S

Get full text

Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk by McIntosh, E D, Malinoski, F J, Randolph, V B

“…There is risk attached to the development of respiratory syncytial virus vaccines, live attenuated or otherwise, but without the acceptance of this risk by…”
Get more information

Safety profile of WinRho anti-D by Hong, F, Ruiz, R, Price, H, Griffiths, A, Malinoski, F, Woloski, M

“…WinRho anti-D is manufactured with multiple processes to minimize the risk of transmitting blood-borne diseases such as viruses. These safety features include…”
Get more information

Pneumonia vaccine by Malinoski, F J, Laufer, D S

Get full text

Strenuous exercise simulating hepatic injury during vaccine trials by Malinoski, F J

“…Three healthy young men participating in phase 1 clinical vaccine trials had unexplained increases in their serum transaminase levels. Retrospective analysis…”
Get more information

Immunologic effects of anti‐D (WinRho‐SD) in children with immune thrombocytopenic purpura by Zimmerman, Sherri A., Malinoski, Frank J., Ware, Russell E.

“…Intravenous immunoglobulin (IVIG) is an effective treatment for immune thrombocytopenic purpura (ITP) that induces transient blockade of the…”
Get full text

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants by RENNELS, MARGARET B, EDWARDS, KATHRYN M, KEYSERLING, HARRY L, REISINGER, KEITH, BLATTER, MARK M, QUATAERT, SALLY A, MADORE, DACE V, CHANG, IH, MALINOSKI, FRANK J, HACKELL, JILL G, PARADISO, PETER R

“…BACKGROUND.Following widespread use of conjugate pneumococcal vaccine, Neisseria meningitidis likely will become the leading cause of bacterial sepsis and…”
Get full text

Limited potential for mosquito transmission of a live, attenuated chikungunya virus vaccine by Turell, M J, Malinoski, F J

“…Studies were conducted to determine the potential for transmission of a live, attenuated chikungunya (CHIK) virus vaccine by orally exposed or virus-inoculated…”
Get more information

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children by BLACK, STEVEN, SHINEFIELD, HENRY, FIREMAN, BRUCE, LEWIS, EDWIN, RAY, PAULA, HANSEN, JOHN R, ELVIN, LAURA, ENSOR, KATHY M, HACKELL, JILL, SIBER, GEORGE, MALINOSKI, FRANK, MADORE, DACE, CHANG, IH, KOHBERGER, ROBERT, WATSON, WENDY, AUSTRIAN, ROBERT, EDWARDS, KATHY

“…OBJECTIVE. METHODS. RESULTS.In the interim analysis in August, 1998, 17 of the 17 cases of invasive disease caused by vaccine serotype in fully vaccinated…”
Get full text

Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys by Malinoski, F J, Hasty, S E, Ussery, M A, Dalrymple, J M

“…The prophylactic efficacy of the broad-spectrum antiviral nucleoside analog ribavirin against flavivirus infection in non-human primates was investigated in a…”
Get more information

Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans by Hoke, Jr, C H, Malinoski, F J, Eckels, K H, Scott, R M, Dubois, D R, Summers, P L, Simms, T, Burrous, J, Hasty, S E, Bancroft, W H

“…To determine safety and immunogenicity, a single 0.5 ml dose of a monovalent live-attenuated dengue (DEN) 4 (341750 Carib) vaccine was given sc to 3 groups of…”
Get more information

Inhibitors of IMP dehydrogenase prevent sindbis virus replication and reduce GTP levels in Aedes albopictus cells by Malinoski, F, Stollar, V

Get more information

Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation by Molrine, Deborah C., Antin, Joseph H., Guinan, Eva C., Soiffer, Robert J., MacDonald, Kristin, Malley, Richard, Malinoski, Frank, Trocciola, Susan, Wilson, Marjorie, Ambrosino, Donna M.

“…Patients undergoing hematopoietic cell transplantation (HCT) are at increased risk for infections with Streptococcus pneumoniaeand have long-lasting, impaired…”
Get full text

Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin by Drulak, M W, Malinoski, F J, Fuller, S A, Stewart, S S, Hoskin, S, Duliege, A M, Sekulovich, R, Burke, R, Winston, S

“…The safety and immunogenicity of four different regimens of CHIRON cytomegalovirus (CMV) gB subunit vaccine combined with MF59 adjuvant and administered to…”
Get more information

Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection by Nachman, Sharon, Kim, Soyeon, King, James, Abrams, Elaine J, Margolis, David, Petru, Ann, Shearer, William, Smith, Elizabeth, Moye, Jack, Blanchard, Suzette, Hawkins, Elizabeth, Bouquin, Pamela, Vink, Peter, Benson, Mindy, Estep, Scharla, Malinoski, Frank

“…Heptavalent pneumococcal conjugate vaccine (PCV) has been shown to be safe and effective in healthy infants and children. However, little is known about its…”
Get full text